Float Short %

6.5

Margin Of Safety %

Put/Call OI Ratio

0.4

EPS Next Q Diff

0.03

EPS Last/This Y

-0.29

EPS This/Next Y

0.37

Price

16.1

Target Price

32.33

Analyst Recom

1.5

Performance Q

-25.42

Relative Volume

1.07

Beta

0.49

Ticker: ADMA

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	ADMA	17	0.30	1.39	104751
2025-08-18	ADMA	17.62	0.36	1.55	79194
2025-08-19	ADMA	17.44	0.38	0.13	82052
2025-08-20	ADMA	17.3	0.38	0.11	82339
2025-08-21	ADMA	17.1	0.37	0.24	84565
2025-08-22	ADMA	17.81	0.36	0.40	85117
2025-08-25	ADMA	17	0.36	0.96	85469
2025-08-26	ADMA	17.09	0.36	0.71	85720
2025-08-27	ADMA	17.25	0.36	1.57	86041
2025-08-28	ADMA	17.38	0.37	3.62	86576
2025-08-29	ADMA	17.25	0.37	1.96	86770
2025-09-02	ADMA	17.2	0.37	0.39	86906
2025-09-03	ADMA	16.93	0.37	0.89	87073
2025-09-04	ADMA	16.9	0.37	1.08	86931
2025-09-05	ADMA	16.88	0.36	0.31	87372
2025-09-08	ADMA	16.42	0.37	4.09	87615
2025-09-09	ADMA	16.39	0.38	0.68	88439
2025-09-10	ADMA	15.74	0.38	4.93	90972
2025-09-11	ADMA	16.13	0.39	0.52	91398
2025-09-12	ADMA	16.1	0.40	0.69	91312
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	ADMA	17.00	6.7	-	0.56
2025-08-18	ADMA	17.62	6.7	-	0.56
2025-08-19	ADMA	17.44	6.7	-	0.56
2025-08-20	ADMA	17.31	6.7	-	0.56
2025-08-21	ADMA	17.10	6.7	-	0.56
2025-08-22	ADMA	17.81	6.7	-	0.56
2025-08-25	ADMA	17.00	6.7	-	0.56
2025-08-26	ADMA	17.10	6.7	-	0.56
2025-08-28	ADMA	17.38	6.7	-	0.56
2025-08-29	ADMA	17.30	6.7	-	0.56
2025-09-02	ADMA	17.19	6.7	-	0.56
2025-09-03	ADMA	16.91	6.7	-	0.56
2025-09-04	ADMA	16.91	6.7	-	0.56
2025-09-05	ADMA	16.87	6.7	-	0.56
2025-09-08	ADMA	16.42	6.7	-	0.56
2025-09-09	ADMA	16.38	6.7	-	0.56
2025-09-10	ADMA	15.76	6.7	-	0.56
2025-09-11	ADMA	16.11	6.7	-	0.56
2025-09-12	ADMA	16.10	6.7	-	0.56
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	ADMA	-6.51	3.81	5.96
2025-08-18	ADMA	-6.73	5.07	5.96
2025-08-19	ADMA	-6.73	5.07	5.96
2025-08-20	ADMA	-6.73	5.07	5.96
2025-08-21	ADMA	-6.73	5.07	5.96
2025-08-22	ADMA	-6.73	5.07	5.96
2025-08-25	ADMA	-6.73	1.85	5.96
2025-08-26	ADMA	-6.73	1.85	5.96
2025-08-27	ADMA	-6.73	1.85	6.49
2025-08-28	ADMA	-6.73	1.85	6.49
2025-08-29	ADMA	-6.73	1.85	6.49
2025-09-02	ADMA	-6.73	3.28	6.49
2025-09-03	ADMA	-6.73	3.28	6.49
2025-09-04	ADMA	-6.73	3.28	6.49
2025-09-05	ADMA	-6.73	3.28	6.49
2025-09-08	ADMA	-6.73	3.09	6.49
2025-09-09	ADMA	-6.73	3.09	6.49
2025-09-10	ADMA	-6.73	3.09	6.49
2025-09-11	ADMA	-6.73	3.09	6.50
2025-09-12	ADMA	-6.73	3.09	6.50
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.15

Avg. EPS Est. Current Quarter

0.16

Avg. EPS Est. Next Quarter

0.18

Insider Transactions

-6.73

Institutional Transactions

3.09

Beta

0.49

Average Sales Estimate Current Quarter

131

Average Sales Estimate Next Quarter

137

Fair Value

16.42

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

37.3

Max Drawdown 5-Year %

-63.1

Target Price

32.33

P/E

18.97

Forward P/E

18.17

PEG

0.62

P/S

8.11

P/B

9.68

P/Free Cash Flow

58.45

EPS

0.85

Average EPS Est. Cur. Y

0.56

EPS Next Y. (Est.)

0.93

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

44.06

Relative Volume

1.07

Return on Equity vs Sector %

27.6

Return on Equity vs Industry %

40.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

ADMA Biologics Inc

Sector: Healthcare

Industry: Biotechnology

Employees: 685

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

stock quote shares ADMA – Adma Biologics Inc Stock Price stock today

news today ADMA – Adma Biologics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ADMA – Adma Biologics Inc yahoo finance google finance

stock history ADMA – Adma Biologics Inc invest stock market

stock prices ADMA premarket after hours

ticker ADMA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ADMA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y